Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol. 27 May Dr D Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice.